🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra
← Volver

Precio actual

53,69 USD

Máx. histórico

108,06

1033 días

Split 1:6 del 25/06/2013

Caída desde máximo

-50,31%

Rango 52 semanas

53,55 – 88,31

Variación hoy

-3,35%

Cierre anterior

55,55

Rango de hoy

53,55 – 56,51

Volumen hoy

2.560.975

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,41%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 3 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/03/2017 12,40 13,00 12,40 12,90 +4,45% 4,84% 613.500
08/03/2017 11,85 12,55 11,85 12,35 +7,39% 5,91% 1.131.800
07/03/2017 11,75 11,95 11,35 11,50 -2,95% 5,11% 319.900
06/03/2017 11,45 11,95 11,35 11,85 +2,60% 5,24% 520.300
03/03/2017 11,20 11,55 10,95 11,55 +3,59% 5,36% 295.100
02/03/2017 11,05 11,45 10,80 11,15 +0,90% 5,88% 183.800
01/03/2017 10,70 11,20 10,60 11,05 +4,25% 5,61% 315.200
28/02/2017 10,85 10,85 10,53 10,60 -2,30% 2,95% 202.400
27/02/2017 10,20 10,90 10,20 10,85 +6,37% 6,86% 248.400
24/02/2017 10,10 10,30 10,05 10,20 +0,49% 2,48% 192.000
23/02/2017 10,50 10,50 10,15 10,15 -3,79% 3,33% 200.600
22/02/2017 10,35 10,80 10,20 10,55 +1,44% 5,80% 277.000
21/02/2017 11,25 11,30 10,30 10,40 -7,56% 8,89% 393.000
17/02/2017 11,90 11,94 10,55 11,25 -0,44% 11,68% 354.200
16/02/2017 11,55 11,60 10,80 11,30 -1,31% 6,93% 340.300
15/02/2017 11,40 11,48 11,10 11,45 +0,88% 3,33% 206.100
14/02/2017 11,40 11,40 10,95 11,35 +0,00% 3,95% 196.200
13/02/2017 11,45 11,62 11,25 11,35 +0,89% 3,23% 209.300
10/02/2017 11,45 11,60 11,05 11,25 -1,75% 4,80% 186.600
09/02/2017 11,40 11,70 11,15 11,45 +0,44% 4,82% 386.800
08/02/2017 11,60 11,65 11,30 11,40 -2,56% 3,02% 229.700
07/02/2017 11,65 11,88 11,60 11,70 +0,43% 2,40% 285.300
06/02/2017 12,05 12,05 11,40 11,65 +3,56% 5,39% 610.100
03/02/2017 11,05 11,25 10,90 11,25 +2,74% 3,17% 207.800
02/02/2017 10,95 11,15 10,65 10,95 +5,29% 4,57% 587.700
01/02/2017 10,55 10,60 10,23 10,40 -0,48% 3,51% 161.700
31/01/2017 10,00 10,48 9,80 10,45 +3,98% 6,80% 164.100
30/01/2017 10,65 10,65 10,05 10,05 -5,63% 5,63% 165.100
27/01/2017 10,30 10,75 10,30 10,65 +4,41% 4,37% 139.600
26/01/2017 10,35 10,55 10,10 10,20 -1,92% 4,35% 186.700